376
Views
15
CrossRef citations to date
0
Altmetric
Review

Physicochemical properties of novel protein kinase inhibitors in relation to their substrate specificity for drug transporters

, , & , PhD (Professor)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ittai B Muller, Adrianus J De Langen, Richard J Honeywell, Elisa Giovannetti & Godefridus J Peters. (2016) Overcoming crizotinib resistance in ALK-rearranged NSCLC with the second-generation ALK-inhibitor ceritinib. Expert Review of Anticancer Therapy 16:2, pages 147-157.
Read now
Godefridus J Peters & Richard J Honeywell. (2015) Drug transport and metabolism of novel anticancer drugs. Expert Opinion on Drug Metabolism & Toxicology 11:5, pages 661-663.
Read now

Articles from other publishers (13)

Fangrui Xiu, Magdalena Rausch, Zhibo Gai, Shanshan Su, Shijun Wang & Michele Visentin. (2023) The Role of Organic Cation Transporters in the Pharmacokinetics, Pharmacodynamics and Drug–Drug Interactions of Tyrosine Kinase Inhibitors. International Journal of Molecular Sciences 24:3, pages 2101.
Crossref
David Malnoë, Olivier Fardel & Pascal Le Corre. (2022) Involvement of Transporters in Intestinal Drug–Drug Interactions of Oral Targeted Anticancer Drugs Assessed by Changes in Drug Absorption Time. Pharmaceutics 14:11, pages 2493.
Crossref
Richard J. Honeywell, Ietje Kathmann, Elisa Giovannetti, Carmelo Tibaldi, Egbert F. Smit, Maria N. Rovithi, Henk M.W. Verheul & Godefridus J. Peters. (2020) Epithelial Transfer of the Tyrosine Kinase Inhibitors Erlotinib, Gefitinib, Afatinib, Crizotinib, Sorafenib, Sunitinib, and Dasatinib: Implications for Clinical Resistance. Cancers 12:11, pages 3322.
Crossref
Nele Van Der Steen, Kaylee Keller, Henk Dekker, Letizia Porcelli, Richard J. Honeywell, Johan Van Meerloo, René J. P. Musters, Ietje Kathmann, Adam E. Frampton, Daniel S. K. Liu, Rob Ruijtenbeek, Christian Rolfo, Patrick Pauwels, Elisa Giovannetti & Godefridus J. Peters. (2020) Crizotinib sensitizes the erlotinib resistant HCC827GR5 cell line by influencing lysosomal function. Journal of Cellular Physiology 235:11, pages 8085-8097.
Crossref
Dominique A. Garrison, Zahra Talebi, Eric D. Eisenmann, Alex Sparreboom & Sharyn D. Baker. (2020) Role of OATP1B1 and OATP1B3 in Drug-Drug Interactions Mediated by Tyrosine Kinase Inhibitors. Pharmaceutics 12:9, pages 856.
Crossref
Cordula Stillhart, Katarina Vučićević, Patrick Augustijns, Abdul W. Basit, Hannah Batchelor, Talia R. Flanagan, Ina Gesquiere, Rick Greupink, Daniel Keszthelyi, Mikko Koskinen, Christine M. Madla, Christophe Matthys, Goran Miljuš, Miriam G. Mooij, Neil Parrott, Anna-Lena Ungell, Saskia N. de Wildt, Mine Orlu, Sandra Klein & Anette Müllertz. (2020) Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review. European Journal of Pharmaceutical Sciences 147, pages 105280.
Crossref
Murányi, Varga, Gyulavári, Pénzes, Németh, Csala, Pethő, Csámpai, Halmos, Peták & Vályi-Nagy. (2019) Novel Crizotinib–GnRH conjugates revealed the significance of lysosomal trapping in GnRH-based drug delivery systems. International Journal of Molecular Sciences 20:22, pages 5590.
Crossref
Bhaskar Venkata Kameswara Subrahmanya Lakkakula, Batoul Farran, Saikrishna Lakkakula, Sujatha Peela, Nagendra Sastry Yarla, Pallaval Veera Bramhachari, Mohammad Amjad Kamal, Madhu Sudhana Saddala & Ganji Purnachandra Nagaraju. (2019) Small molecule tyrosine kinase inhibitors and pancreatic cancer—Trials and troubles. Seminars in Cancer Biology 56, pages 149-167.
Crossref
Daniel de Klerk, Richard Honeywell, Gerrit Jansen & Godefridus Peters. (2018) Transporter and Lysosomal Mediated (Multi)drug Resistance to Tyrosine Kinase Inhibitors and Potential Strategies to Overcome Resistance. Cancers 10:12, pages 503.
Crossref
Paola Perego, Georg Hempel, Stig Linder, Tracey D. Bradshaw, Annette K. Larsen, Godefridus J. Peters & Roger M. Phillips. (2017) Cellular pharmacology studies of anticancer agents: recommendations from the EORTC-PAMM group. Cancer Chemotherapy and Pharmacology 81:3, pages 427-441.
Crossref
C. G. Da Silva, Godefridus J. Peters, Ferry Ossendorp & Luis J. Cruz. (2017) The potential of multi-compound nanoparticles to bypass drug resistance in cancer. Cancer Chemotherapy and Pharmacology 80:5, pages 881-894.
Crossref
Zhiyong Yan, Zonghua Wang, Zhuang Miao & Yang Liu. (2015) Dye-Sensitized and Localized Surface Plasmon Resonance Enhanced Visible-Light Photoelectrochemical Biosensors for Highly Sensitive Analysis of Protein Kinase Activity. Analytical Chemistry 88:1, pages 922-929.
Crossref
Suneet Shukla, Atish Patel & Suresh V. Ambudkar. 2016. ABC Transporters - 40 Years on. ABC Transporters - 40 Years on 227 272 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.